Literature DB >> 35232819

Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action.

Janani Rangaswami1, Vivek Bhalla2,3, Glenn M Chertow2,3, Robert A Harrington3, Alexander Staruschenko4, Katherine Tuttle5,6, Eugene Braunwald7,8.   

Abstract

Entities:  

Keywords:  SGLT2 inhibitors; cardiorenal; heart failure; multidisciplinary

Mesh：

Substances：

Year:  2022        PMID： 35232819      PMCID： PMC9269572          DOI： 10.2215/CJN.00470122

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  9 in total

Review 1.  AKI-A Relevant Safety End Point?

Authors:  Ian E McCoy; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2020-02-07       Impact factor: 8.860

Review 2.  Cardiovascular safety profile of currently available diabetic drugs.

Authors:  Komola Azimova; Zinnia San Juan; Debabrata Mukherjee
Journal:  Ochsner J       Date:  2014

Review 3.  Representation of Chronic Kidney Disease in Randomized Controlled Trials Among Patients With Heart failure With Reduced Ejection Fraction: A Systematic Review.

Authors:  Kevin Bryan Lo; Hani Essa; Ammaar Wattoo; Asma Gulab; Hamza Akhtar; Hussein Al Sudani; Lucas Angelim; Beth Helfman; Eric Peterson; Sophia Brousas; Isabel Whybrow-Huppatz; Ali Yazdanyar; Rajiv Sankaranarayanan; Janani Rangaswami
Journal:  Curr Probl Cardiol       Date:  2021-11-14       Impact factor: 5.200

4.  A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

Authors:  Cynthia Delgado; Mukta Baweja; Deidra C Crews; Nwamaka D Eneanya; Crystal A Gadegbeku; Lesley A Inker; Mallika L Mendu; W Greg Miller; Marva M Moxey-Mims; Glenda V Roberts; Wendy L St Peter; Curtis Warfield; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2021-09-23       Impact factor: 10.121

5.  Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.

Authors:  Janani Rangaswami; Kevin Bryan Lo; Muthiah Vaduganathan; Roy O Mathew
Journal:  J Am Coll Cardiol       Date:  2021-10-19       Impact factor: 24.094

6.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.

Authors:  Glenn M Chertow; Sharon-Lise T Normand; Barbara J McNeil
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

Review 7.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

Review 8.  Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine.

Authors: 
Journal:  Med Chir Rev       Date:  1836-07-01

9.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

Authors:  Milton Packer; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Peter Carson; James Januzzi; Subodh Verma; Hiroyuki Tsutsui; Martina Brueckmann; Waheed Jamal; Karen Kimura; Janet Schnee; Cordula Zeller; Daniel Cotton; Edimar Bocchi; Michael Böhm; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure; Nadia Giannetti; Stefan Janssens; Jian Zhang; Jose R Gonzalez Juanatey; Sanjay Kaul; Hans-Peter Brunner-La Rocca; Bela Merkely; Stephen J Nicholls; Sergio Perrone; Ileana Pina; Piotr Ponikowski; Naveed Sattar; Michele Senni; Marie-France Seronde; Jindrich Spinar; Iain Squire; Stefano Taddei; Christoph Wanner; Faiez Zannad
Journal:  N Engl J Med       Date:  2020-08-28       Impact factor: 176.079
  9 in total
  1 in total

1.  Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor.

Authors:  Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-28       Impact factor: 10.614
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.